Long-term survival outcomes of duodenal adenocarcinoma: A cohort study with 15-year single-center experience

doi:10.4240/wjgs.v17.i2.101365

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (546)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

HTML

245

Figures (1-3)

113

Tables (1-2)

Sum=468

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=50

Feb 27, 2025 (publication date) through Mar 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Surg. Feb 27, 2025; 17(2): 101365
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.101365

Full Size Figure Download Figure

Figure 3 Survival of patients with duodenal carcinoma undergoing adjuvant therapy. A: Overall survival (OS) in patients with stage II and stage III duodenal adenocarcinoma (DA) compared with and without adjuvant therapy; B: Disease-free survival (DFS) in patients with stage II and stage III DA compared with and without adjuvant therapy; C: OS in patients with stage II DA compared with and without adjuvant therapy; D: Adjuvant therapy in patients with stage II and stage III DFS with and without treatment; E: OS with and without treatment in patients with stage III; F: DFS with and without treatment in patients with stage III.

Citation: Xie QF, Long LS, Luo YY, Lu MT, Ming WK, Zhao LY, Liu H. Long-term survival outcomes of duodenal adenocarcinoma: A cohort study with 15-year single-center experience. World J Gastrointest Surg 2025; 17(2): 101365
URL: https://www.wjgnet.com/1948-9366/full/v17/i2/101365.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i2.101365